TMT1B and central nervous system cancer: The classical and mesenchymal subtypes expressed significantly higher levels of METTL7B as compared to the proneural subtype (Figure S1E), and METTL7B expression correlated with worse survival in patients with IDH-wild-type glioma in TCGA and CGGA databases (Figure S1F).